title: 18F-FDG positron emission tomography in oncology: main indications.
abstract: The development of molecular and functional imaging with new imaging techniques such as computed tomography, magnetic resonance imaging, and positron emission tomography (PET) among others, has greatly improved the detection of tumors, tumor staging, and the detection of possible recurrences. Furthermore, the combination of these different imaging modalities and the continual development of radiotracers for PET have advanced our understanding and knowledge of the different pathophysiological processes in cancer, thereby helping to make treatment more efficacious, improving patients' quality of life, and increasing survival. PET is one of the imaging techniques that has attracted the most interest in recent years for its diagnostic capabilities. Its ability to anatomically locate pathologic foci of metabolic activity has revolutionized the detection and staging of many tumors, exponentially broadening its potential indications not only in oncology but also in other fields such as cardiology, neurology, and inflammatory and infectious diseases.
authors.affiliation: Unitat PET-TC IDI, Hospital Universitari de Bellvitge, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España. Electronic address: joseluis.vercher@idi.gencat.cat.
authors.forename: J L
authors.initials: JL
authors.lastname: Vercher-Conejero
authors.affiliation: Unitat PET-TC IDI, Hospital Universitari de Bellvitge, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España.
authors.forename: C
authors.initials: C
authors.lastname: Gámez Cenzano
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D055815:Young Adult
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: (18)F-FDG PET/TC; 18F-FDG PET/CT; Breast cancer; Colorectal cancer; Cáncer colorrectal; Cáncer de mama; Cáncer de pulmón; Gastrointestinal tumors; Genitourinary tumors; Gynecological tumors; Indicaciones PET; Indications for PET; Linfoma; Lung cancer; Lymphoma; Melanoma; Neuro-oncology; Neuro-oncología; Oncology; Oncología; Tumores de cabeza y cuello; Tumores de origen desconocido; Tumores gastrointestinales; Tumores genitourinarios; Tumores ginecológicos; Tumors of the head and neck; Tumors of unknown origin